Related Experiment Videos
[Treatment of urogenital neoplasms in males]
Schweizerische Medizinische Wochenschrift
|September 9, 1978
Abstract:
The carcinomas of the male genitourinary tract--prostate, testicle, bladder, kidney and penis--are discussed with regard to incidence, prognosis and therapeutic possibilities. The results of drug treatment, especially for prostatic and non-seminoma testicular cancers, are presented in detail.
Insights
This study reviews male genitourinary tract carcinomas, focusing on incidence, prognosis, and treatment options. It details drug therapy outcomes for prostate and non-seminoma testicular cancers.
Area of Science:
- Urology
- Oncology
Context:
- Male genitourinary tract cancers encompass prostate, testicular, bladder, kidney, and penile carcinomas.
- Understanding the epidemiology and therapeutic landscape of these malignancies is crucial for patient outcomes.
Purpose:
- To provide a comprehensive overview of male genitourinary carcinomas.
- To detail the incidence, prognosis, and therapeutic possibilities for these cancers.
- To present specific results of drug treatments for prostate and non-seminoma testicular cancers.
Summary:
- The review covers key aspects of male genitourinary cancers, including their occurrence rates and survival predictions.
- Emphasis is placed on evaluating the effectiveness of various drug treatments, particularly for advanced or metastatic prostate cancer and non-seminoma testicular tumors.
Impact:
- Informs clinicians and researchers about the current status of male genitourinary cancer management.
- Highlights the efficacy of specific chemotherapeutic regimens, guiding future treatment strategies.
- Contributes to improved understanding and potential advancements in the care of these malignancies.